Kenneth MacLean
Concepts (462)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Homocystinuria | 14 | 2024 | 62 | 5.930 |
Why?
| | Cystathionine beta-Synthase | 22 | 2024 | 65 | 4.550 |
Why?
| | Taurine | 6 | 2020 | 41 | 2.460 |
Why?
| | Liver | 17 | 2026 | 1887 | 2.220 |
Why?
| | Betaine | 10 | 2024 | 65 | 2.200 |
Why?
| | Homocysteine | 12 | 2024 | 151 | 1.600 |
Why?
| | Betaine-Homocysteine S-Methyltransferase | 2 | 2019 | 9 | 0.940 |
Why?
| | Oxidation-Reduction | 6 | 2024 | 1087 | 0.910 |
Why?
| | Tetrahydrofolates | 1 | 2024 | 16 | 0.850 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2024 | 23 | 0.850 |
Why?
| | Methionine | 4 | 2021 | 162 | 0.820 |
Why?
| | Disease Models, Animal | 22 | 2026 | 4557 | 0.770 |
Why?
| | Down Syndrome | 10 | 2023 | 534 | 0.760 |
Why?
| | Mice | 44 | 2026 | 18339 | 0.720 |
Why?
| | Cysteine | 4 | 2020 | 210 | 0.630 |
Why?
| | Mice, Inbred C57BL | 21 | 2024 | 5992 | 0.620 |
Why?
| | Fatty Liver | 6 | 2013 | 251 | 0.570 |
Why?
| | Sulfur | 2 | 2014 | 64 | 0.560 |
Why?
| | Folic Acid | 3 | 2026 | 199 | 0.550 |
Why?
| | Sulfinic Acids | 1 | 2018 | 6 | 0.550 |
Why?
| | Animals | 50 | 2026 | 38058 | 0.540 |
Why?
| | Choline | 2 | 2017 | 136 | 0.540 |
Why?
| | Sulfhydryl Compounds | 2 | 2018 | 189 | 0.540 |
Why?
| | Aminobutyrates | 1 | 2018 | 31 | 0.530 |
Why?
| | Pyruvaldehyde | 1 | 2018 | 50 | 0.520 |
Why?
| | Hyperglycinemia, Nonketotic | 3 | 2026 | 56 | 0.520 |
Why?
| | Phosphatidylethanolamine N-Methyltransferase | 1 | 2017 | 8 | 0.520 |
Why?
| | Endoplasmic Reticulum | 5 | 2014 | 266 | 0.510 |
Why?
| | Non-alcoholic Fatty Liver Disease | 4 | 2024 | 266 | 0.470 |
Why?
| | Cystathionine | 2 | 2012 | 22 | 0.460 |
Why?
| | Phospholipids | 1 | 2017 | 213 | 0.450 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 4 | 2021 | 35 | 0.440 |
Why?
| | Mice, Knockout | 10 | 2020 | 3121 | 0.440 |
Why?
| | Abnormalities, Multiple | 3 | 2007 | 197 | 0.430 |
Why?
| | Induced Pluripotent Stem Cells | 3 | 2023 | 276 | 0.430 |
Why?
| | Apolipoprotein A-I | 2 | 2012 | 39 | 0.430 |
Why?
| | Hepatocytes | 3 | 2024 | 223 | 0.420 |
Why?
| | Glycine | 2 | 2026 | 187 | 0.410 |
Why?
| | Thrombosis | 2 | 2011 | 393 | 0.400 |
Why?
| | Neural Stem Cells | 4 | 2023 | 166 | 0.400 |
Why?
| | Apolipoproteins A | 1 | 2012 | 18 | 0.370 |
Why?
| | Aryldialkylphosphatase | 1 | 2012 | 17 | 0.370 |
Why?
| | Mice, Transgenic | 10 | 2021 | 2182 | 0.350 |
Why?
| | Fragile X Syndrome | 2 | 2009 | 118 | 0.340 |
Why?
| | Transcription Factors | 10 | 2024 | 1741 | 0.330 |
Why?
| | Mutation | 9 | 2024 | 4089 | 0.330 |
Why?
| | Chemokines | 1 | 2011 | 218 | 0.320 |
Why?
| | Hydrogen Sulfide | 2 | 2020 | 48 | 0.310 |
Why?
| | Trans-Activators | 3 | 2007 | 405 | 0.310 |
Why?
| | S-Adenosylmethionine | 6 | 2006 | 59 | 0.280 |
Why?
| | Male | 35 | 2026 | 72315 | 0.280 |
Why?
| | Endoplasmic Reticulum Stress | 3 | 2014 | 120 | 0.270 |
Why?
| | Biomarkers | 2 | 2019 | 4271 | 0.270 |
Why?
| | Dietary Supplements | 4 | 2014 | 576 | 0.270 |
Why?
| | Apoptosis | 3 | 2013 | 2430 | 0.270 |
Why?
| | Urination Disorders | 1 | 2007 | 15 | 0.260 |
Why?
| | Ectodermal Dysplasia | 1 | 2007 | 19 | 0.260 |
Why?
| | Lipids | 1 | 2012 | 710 | 0.260 |
Why?
| | Saccharomyces cerevisiae | 2 | 2002 | 579 | 0.250 |
Why?
| | Myoblasts | 1 | 2007 | 84 | 0.240 |
Why?
| | Fingers | 1 | 2007 | 107 | 0.240 |
Why?
| | Phenotype | 6 | 2024 | 3162 | 0.240 |
Why?
| | Cleft Lip | 1 | 2007 | 72 | 0.240 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2021 | 269 | 0.240 |
Why?
| | Protein Precursors | 1 | 2007 | 137 | 0.240 |
Why?
| | Cleft Palate | 1 | 2007 | 89 | 0.240 |
Why?
| | Metabolome | 2 | 2021 | 384 | 0.240 |
Why?
| | DNA-Binding Proteins | 4 | 2007 | 1499 | 0.230 |
Why?
| | Cystathionine gamma-Lyase | 3 | 2020 | 13 | 0.230 |
Why?
| | Carbon | 2 | 2024 | 203 | 0.230 |
Why?
| | Oxidative Stress | 6 | 2022 | 1339 | 0.230 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2007 | 214 | 0.230 |
Why?
| | Body Patterning | 2 | 2014 | 138 | 0.220 |
Why?
| | Serine | 1 | 2026 | 145 | 0.220 |
Why?
| | Eye Abnormalities | 1 | 2005 | 17 | 0.220 |
Why?
| | Tooth Abnormalities | 1 | 2005 | 16 | 0.220 |
Why?
| | Chromosomes, Human, Pair 6 | 1 | 2005 | 46 | 0.220 |
Why?
| | Amino Acids | 2 | 2020 | 521 | 0.220 |
Why?
| | Tumor Suppressor Proteins | 1 | 2007 | 321 | 0.220 |
Why?
| | Trisomy | 4 | 2017 | 78 | 0.220 |
Why?
| | Chromosome Deletion | 1 | 2005 | 124 | 0.210 |
Why?
| | Humans | 42 | 2026 | 144759 | 0.210 |
Why?
| | Sp1 Transcription Factor | 1 | 2003 | 25 | 0.210 |
Why?
| | Face | 1 | 2005 | 173 | 0.200 |
Why?
| | Functional Laterality | 1 | 2004 | 241 | 0.190 |
Why?
| | Nuclear Proteins | 2 | 2013 | 748 | 0.190 |
Why?
| | Female | 24 | 2024 | 78271 | 0.190 |
Why?
| | Uterine Artery | 2 | 2020 | 75 | 0.190 |
Why?
| | Connective Tissue | 1 | 2002 | 39 | 0.180 |
Why?
| | Cells | 1 | 2002 | 25 | 0.180 |
Why?
| | Myocytes, Cardiac | 1 | 2007 | 556 | 0.180 |
Why?
| | Diet, High-Fat | 2 | 2024 | 261 | 0.180 |
Why?
| | Adenosylhomocysteinase | 1 | 2021 | 9 | 0.170 |
Why?
| | Glycine Hydroxymethyltransferase | 1 | 2021 | 16 | 0.170 |
Why?
| | Heme | 2 | 2002 | 89 | 0.170 |
Why?
| | Polyamines | 1 | 2021 | 42 | 0.160 |
Why?
| | Insulin Resistance | 2 | 2024 | 1241 | 0.160 |
Why?
| | Liver Failure | 1 | 2021 | 83 | 0.160 |
Why?
| | Stress, Psychological | 1 | 2009 | 1152 | 0.160 |
Why?
| | Syndrome | 3 | 2007 | 380 | 0.160 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2020 | 10 | 0.160 |
Why?
| | Lipotropic Agents | 2 | 2012 | 5 | 0.160 |
Why?
| | tau Proteins | 2 | 2012 | 115 | 0.160 |
Why?
| | Quinone Reductases | 1 | 2020 | 17 | 0.160 |
Why?
| | Mutation, Missense | 1 | 2002 | 340 | 0.160 |
Why?
| | Leigh Disease | 1 | 2020 | 22 | 0.160 |
Why?
| | Myometrium | 1 | 2020 | 38 | 0.160 |
Why?
| | Association Learning | 2 | 2011 | 71 | 0.160 |
Why?
| | Lipogenesis | 3 | 2019 | 62 | 0.160 |
Why?
| | Mitochondria | 3 | 2023 | 984 | 0.150 |
Why?
| | Ethanol | 2 | 2016 | 627 | 0.150 |
Why?
| | Growth Differentiation Factor 10 | 1 | 2019 | 1 | 0.150 |
Why?
| | SNARE Proteins | 1 | 2019 | 40 | 0.150 |
Why?
| | Umbilical Arteries | 1 | 2020 | 52 | 0.150 |
Why?
| | Interleukin-1beta | 2 | 2011 | 395 | 0.150 |
Why?
| | Cell Differentiation | 6 | 2023 | 2050 | 0.140 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 181 | 0.140 |
Why?
| | Hyperhomocysteinemia | 2 | 2009 | 27 | 0.140 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2020 | 266 | 0.140 |
Why?
| | Glutathione | 3 | 2020 | 375 | 0.140 |
Why?
| | PPAR gamma | 1 | 2019 | 176 | 0.140 |
Why?
| | Recombinant Proteins | 2 | 2001 | 1370 | 0.140 |
Why?
| | gamma-Glutamyltransferase | 1 | 2018 | 42 | 0.130 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2011 | 1217 | 0.130 |
Why?
| | Brachial Artery | 1 | 2019 | 206 | 0.130 |
Why?
| | Respiratory Hypersensitivity | 1 | 2018 | 65 | 0.130 |
Why?
| | Proteostasis Deficiencies | 1 | 2017 | 5 | 0.130 |
Why?
| | Brain | 5 | 2026 | 2933 | 0.130 |
Why?
| | Hep G2 Cells | 2 | 2019 | 74 | 0.130 |
Why?
| | Autophagy | 1 | 2019 | 286 | 0.130 |
Why?
| | Estradiol | 1 | 2020 | 533 | 0.120 |
Why?
| | Inflammation | 4 | 2019 | 2878 | 0.120 |
Why?
| | Cell Death | 2 | 2024 | 383 | 0.120 |
Why?
| | Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 11 | 0.120 |
Why?
| | Fatty Liver, Alcoholic | 1 | 2016 | 14 | 0.120 |
Why?
| | Hydatidiform Mole | 1 | 2015 | 3 | 0.120 |
Why?
| | Transcription Factor TFIIIB | 1 | 1995 | 5 | 0.120 |
Why?
| | Embryonic Development | 3 | 2006 | 125 | 0.120 |
Why?
| | Chromosomes, Human, Pair 14 | 1 | 1995 | 21 | 0.120 |
Why?
| | Molecular Sequence Data | 6 | 2003 | 2930 | 0.120 |
Why?
| | Genomic Imprinting | 1 | 2015 | 26 | 0.120 |
Why?
| | Animals, Newborn | 4 | 2024 | 902 | 0.120 |
Why?
| | Fibroblasts | 4 | 2012 | 1034 | 0.110 |
Why?
| | Cells, Cultured | 6 | 2022 | 4154 | 0.110 |
Why?
| | Diet | 3 | 2011 | 1273 | 0.110 |
Why?
| | Obesity | 3 | 2024 | 3077 | 0.110 |
Why?
| | PTEN Phosphohydrolase | 1 | 2016 | 164 | 0.110 |
Why?
| | Host Cell Factor C1 | 1 | 2014 | 15 | 0.110 |
Why?
| | Hippocampus | 3 | 2026 | 965 | 0.110 |
Why?
| | Cysteine Dioxygenase | 1 | 2014 | 3 | 0.110 |
Why?
| | RNA, Messenger | 4 | 2014 | 2832 | 0.110 |
Why?
| | Carboxy-Lyases | 1 | 2014 | 10 | 0.110 |
Why?
| | Antigens, Polyomavirus Transforming | 1 | 1994 | 15 | 0.100 |
Why?
| | Cell Transformation, Viral | 1 | 1994 | 23 | 0.100 |
Why?
| | Triglycerides | 5 | 2018 | 520 | 0.100 |
Why?
| | Child, Preschool | 5 | 2020 | 11787 | 0.100 |
Why?
| | Li-Fraumeni Syndrome | 1 | 1994 | 15 | 0.100 |
Why?
| | Protein Denaturation | 2 | 2012 | 75 | 0.100 |
Why?
| | Escherichia coli | 4 | 2002 | 854 | 0.100 |
Why?
| | DNA Methylation | 2 | 2018 | 681 | 0.100 |
Why?
| | Sulfurtransferases | 1 | 2013 | 9 | 0.100 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 477 | 0.100 |
Why?
| | Fetal Growth Retardation | 1 | 2020 | 587 | 0.100 |
Why?
| | Base Sequence | 6 | 2003 | 2190 | 0.100 |
Why?
| | Glutaredoxins | 1 | 2013 | 15 | 0.100 |
Why?
| | Heat-Shock Proteins | 1 | 2014 | 138 | 0.100 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2018 | 675 | 0.100 |
Why?
| | Cell Line | 3 | 2019 | 2882 | 0.100 |
Why?
| | Aldehydes | 1 | 2014 | 142 | 0.100 |
Why?
| | Cholesterol | 2 | 2013 | 406 | 0.100 |
Why?
| | Adenosine Triphosphatases | 1 | 2014 | 162 | 0.100 |
Why?
| | Peroxiredoxins | 1 | 2013 | 26 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 341 | 0.100 |
Why?
| | Liver Diseases, Alcoholic | 1 | 2014 | 97 | 0.100 |
Why?
| | Blotting, Western | 2 | 2014 | 1187 | 0.100 |
Why?
| | Avoidance Learning | 2 | 2012 | 64 | 0.090 |
Why?
| | Tunicamycin | 1 | 2012 | 11 | 0.090 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2015 | 427 | 0.090 |
Why?
| | Cognition | 2 | 2012 | 1266 | 0.090 |
Why?
| | Adult | 6 | 2020 | 40449 | 0.090 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2012 | 23 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 983 | 0.090 |
Why?
| | Galantamine | 1 | 2011 | 3 | 0.090 |
Why?
| | Lyases | 1 | 2012 | 16 | 0.090 |
Why?
| | Palmitic Acid | 1 | 2011 | 42 | 0.090 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2013 | 190 | 0.090 |
Why?
| | Necrosis | 1 | 2012 | 244 | 0.090 |
Why?
| | Promoter Regions, Genetic | 4 | 2005 | 1257 | 0.090 |
Why?
| | Chemokine CCL4 | 1 | 2011 | 31 | 0.090 |
Why?
| | Child | 4 | 2019 | 22633 | 0.090 |
Why?
| | Zebrafish Proteins | 1 | 2014 | 311 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2014 | 905 | 0.080 |
Why?
| | Young Adult | 3 | 2020 | 14105 | 0.080 |
Why?
| | Metabolomics | 1 | 2017 | 727 | 0.080 |
Why?
| | Methylation | 1 | 2011 | 242 | 0.080 |
Why?
| | Infant | 6 | 2019 | 10034 | 0.080 |
Why?
| | Sucrose | 1 | 2011 | 112 | 0.080 |
Why?
| | Proteins | 2 | 2013 | 1021 | 0.080 |
Why?
| | Interleukin-1alpha | 1 | 2011 | 57 | 0.080 |
Why?
| | Neuroblastoma | 1 | 2012 | 174 | 0.080 |
Why?
| | Hypoxia | 1 | 2018 | 1199 | 0.080 |
Why?
| | Stem Cell Transplantation | 1 | 2012 | 191 | 0.080 |
Why?
| | Dietary Fats | 1 | 2013 | 314 | 0.080 |
Why?
| | Kinetics | 4 | 2020 | 1627 | 0.080 |
Why?
| | Adolescent | 3 | 2019 | 22428 | 0.080 |
Why?
| | Placenta | 2 | 2015 | 780 | 0.080 |
Why?
| | Interleukin-17 | 1 | 2011 | 118 | 0.080 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2010 | 42 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2014 | 737 | 0.080 |
Why?
| | Cell Line, Tumor | 2 | 2011 | 3540 | 0.080 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2011 | 139 | 0.080 |
Why?
| | Blood Coagulation | 1 | 2011 | 268 | 0.080 |
Why?
| | Serine Endopeptidases | 1 | 2010 | 128 | 0.080 |
Why?
| | HEK293 Cells | 1 | 2012 | 744 | 0.080 |
Why?
| | Cell Division | 2 | 2002 | 766 | 0.080 |
Why?
| | Hemostasis | 1 | 2010 | 102 | 0.080 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 2 | 2024 | 55 | 0.080 |
Why?
| | Acetylcysteine | 1 | 2010 | 139 | 0.080 |
Why?
| | Freezing Reaction, Cataleptic | 1 | 2009 | 27 | 0.080 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2007 | 381 | 0.070 |
Why?
| | Extracellular Matrix Proteins | 1 | 2010 | 158 | 0.070 |
Why?
| | Restraint, Physical | 1 | 2009 | 75 | 0.070 |
Why?
| | Swimming | 1 | 2009 | 50 | 0.070 |
Why?
| | Electroshock | 1 | 2009 | 145 | 0.070 |
Why?
| | Atherosclerosis | 1 | 2013 | 409 | 0.070 |
Why?
| | Hypertriglyceridemia | 1 | 2009 | 44 | 0.070 |
Why?
| | Tumor Cells, Cultured | 3 | 2002 | 919 | 0.070 |
Why?
| | Alcohol Drinking | 1 | 2016 | 826 | 0.070 |
Why?
| | Pregnancy | 6 | 2020 | 7190 | 0.070 |
Why?
| | Genetic Variation | 1 | 2013 | 983 | 0.070 |
Why?
| | Karyotyping | 2 | 2006 | 106 | 0.070 |
Why?
| | Rats | 4 | 2011 | 5597 | 0.070 |
Why?
| | Corticosterone | 1 | 2009 | 244 | 0.070 |
Why?
| | Blood Coagulation Disorders | 1 | 2010 | 189 | 0.070 |
Why?
| | Liver Cirrhosis | 1 | 2010 | 288 | 0.070 |
Why?
| | Cognition Disorders | 1 | 2012 | 538 | 0.070 |
Why?
| | Gene Expression Regulation | 4 | 2019 | 2608 | 0.070 |
Why?
| | Exploratory Behavior | 1 | 2008 | 86 | 0.070 |
Why?
| | Fibrosis | 1 | 2010 | 548 | 0.070 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2007 | 33 | 0.060 |
Why?
| | Lamin Type A | 1 | 2007 | 51 | 0.060 |
Why?
| | Interleukin-6 | 1 | 2011 | 780 | 0.060 |
Why?
| | Taste | 1 | 2009 | 239 | 0.060 |
Why?
| | Memory | 1 | 2009 | 295 | 0.060 |
Why?
| | Glutamine | 1 | 2007 | 109 | 0.060 |
Why?
| | Nerve Tissue Proteins | 1 | 2010 | 592 | 0.060 |
Why?
| | Attention | 1 | 2010 | 457 | 0.060 |
Why?
| | Aging | 3 | 2012 | 1966 | 0.060 |
Why?
| | Point Mutation | 1 | 2007 | 243 | 0.060 |
Why?
| | Glycine Dehydrogenase (Decarboxylating) | 1 | 2026 | 13 | 0.060 |
Why?
| | Pedigree | 1 | 2007 | 514 | 0.060 |
Why?
| | Glucose-6-Phosphatase | 1 | 2005 | 31 | 0.060 |
Why?
| | Chromosomes, Human, Pair 8 | 1 | 2006 | 38 | 0.060 |
Why?
| | Structure-Activity Relationship | 1 | 2007 | 570 | 0.060 |
Why?
| | Arginine | 1 | 2007 | 262 | 0.060 |
Why?
| | Placental Circulation | 1 | 2006 | 70 | 0.060 |
Why?
| | Social Behavior | 1 | 2008 | 288 | 0.060 |
Why?
| | Chromosome Banding | 1 | 2005 | 17 | 0.060 |
Why?
| | Cloning, Molecular | 3 | 2001 | 540 | 0.060 |
Why?
| | Amino Acid Sequence | 3 | 2014 | 2155 | 0.060 |
Why?
| | Emotions | 1 | 2010 | 578 | 0.050 |
Why?
| | Models, Biological | 1 | 2012 | 1821 | 0.050 |
Why?
| | Neovascularization, Physiologic | 1 | 2006 | 194 | 0.050 |
Why?
| | Sp3 Transcription Factor | 1 | 2003 | 6 | 0.050 |
Why?
| | Alanine Transaminase | 2 | 2016 | 151 | 0.050 |
Why?
| | Serum Albumin | 1 | 2004 | 147 | 0.050 |
Why?
| | Trophoblasts | 1 | 2006 | 216 | 0.050 |
Why?
| | Hydrocephalus | 1 | 2024 | 111 | 0.050 |
Why?
| | Organ Specificity | 1 | 2003 | 312 | 0.050 |
Why?
| | DNA Primers | 3 | 2005 | 512 | 0.050 |
Why?
| | Blood Physiological Phenomena | 1 | 2002 | 12 | 0.050 |
Why?
| | Biopolymers | 1 | 2002 | 35 | 0.050 |
Why?
| | Carbon-Carbon Ligases | 1 | 2002 | 2 | 0.050 |
Why?
| | Repressor Proteins | 1 | 2006 | 437 | 0.050 |
Why?
| | DNA, Complementary | 2 | 2000 | 276 | 0.050 |
Why?
| | Enzyme Stability | 1 | 2002 | 73 | 0.050 |
Why?
| | Propionates | 1 | 2002 | 39 | 0.050 |
Why?
| | Cricetulus | 1 | 2002 | 118 | 0.050 |
Why?
| | Genotype | 1 | 2007 | 1833 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2000 | 396 | 0.040 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2002 | 93 | 0.040 |
Why?
| | Cricetinae | 1 | 2002 | 303 | 0.040 |
Why?
| | Reperfusion Injury | 1 | 2004 | 300 | 0.040 |
Why?
| | Green Fluorescent Proteins | 2 | 2014 | 405 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2012 | 1907 | 0.040 |
Why?
| | Isoenzymes | 1 | 2002 | 299 | 0.040 |
Why?
| | United States | 1 | 2019 | 15966 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2002 | 406 | 0.040 |
Why?
| | Signal Transduction | 3 | 2016 | 5226 | 0.040 |
Why?
| | Pyridoxal Phosphate | 1 | 2000 | 25 | 0.040 |
Why?
| | In Situ Hybridization, Fluorescence | 2 | 2006 | 322 | 0.040 |
Why?
| | Chromosome Mapping | 2 | 2006 | 510 | 0.040 |
Why?
| | Anxiety | 1 | 2008 | 1109 | 0.040 |
Why?
| | Glucose | 1 | 2005 | 1047 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2020 | 62 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 331 | 0.040 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2019 | 32 | 0.040 |
Why?
| | R-SNARE Proteins | 1 | 2019 | 19 | 0.040 |
Why?
| | Down-Regulation | 1 | 2002 | 627 | 0.040 |
Why?
| | Acidosis, Lactic | 1 | 2020 | 45 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2020 | 131 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2023 | 621 | 0.040 |
Why?
| | Ovariectomy | 1 | 2020 | 162 | 0.040 |
Why?
| | Homozygote | 1 | 2020 | 199 | 0.040 |
Why?
| | Pregnancy Trimester, Third | 1 | 2020 | 115 | 0.040 |
Why?
| | Mice, Mutant Strains | 2 | 2011 | 299 | 0.040 |
Why?
| | Catalysis | 1 | 2000 | 322 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2020 | 126 | 0.040 |
Why?
| | Lysosomes | 1 | 2019 | 128 | 0.040 |
Why?
| | Infant, Small for Gestational Age | 1 | 2020 | 109 | 0.040 |
Why?
| | Sequence Deletion | 2 | 2002 | 193 | 0.040 |
Why?
| | Brain Diseases | 1 | 2020 | 152 | 0.040 |
Why?
| | Behavior, Animal | 2 | 2012 | 519 | 0.040 |
Why?
| | Progesterone | 1 | 2020 | 255 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 59 | 0.040 |
Why?
| | Macaca | 1 | 2018 | 65 | 0.040 |
Why?
| | Microtubule-Associated Proteins | 1 | 2019 | 196 | 0.040 |
Why?
| | Ligands | 1 | 2000 | 673 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2005 | 1054 | 0.030 |
Why?
| | Gluconeogenesis | 1 | 2018 | 83 | 0.030 |
Why?
| | Protein Transport | 1 | 2019 | 441 | 0.030 |
Why?
| | Diet, Western | 1 | 2018 | 86 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2020 | 6429 | 0.030 |
Why?
| | Estrogens | 1 | 2020 | 380 | 0.030 |
Why?
| | Ultrasonography, Prenatal | 1 | 2020 | 294 | 0.030 |
Why?
| | Ultraviolet Rays | 1 | 2000 | 388 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2000 | 750 | 0.030 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2017 | 42 | 0.030 |
Why?
| | Protein Structure, Tertiary | 2 | 2014 | 862 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2020 | 476 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 640 | 0.030 |
Why?
| | Gestational Age | 1 | 2020 | 975 | 0.030 |
Why?
| | Alternative Splicing | 1 | 1998 | 247 | 0.030 |
Why?
| | Fatty Acids | 1 | 2019 | 450 | 0.030 |
Why?
| | Hybrid Cells | 1 | 1995 | 49 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1716 | 0.030 |
Why?
| | Protein Carbonylation | 1 | 2016 | 57 | 0.030 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 1995 | 22 | 0.030 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 98 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 462 | 0.030 |
Why?
| | Quantitative Trait Loci | 1 | 2018 | 374 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2024 | 1982 | 0.030 |
Why?
| | Family | 1 | 2020 | 679 | 0.030 |
Why?
| | Genes, Immediate-Early | 1 | 1995 | 26 | 0.030 |
Why?
| | Immediate-Early Proteins | 1 | 1995 | 48 | 0.030 |
Why?
| | Branchial Region | 1 | 2014 | 37 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2014 | 60 | 0.030 |
Why?
| | Oxidoreductases | 1 | 2014 | 96 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1886 | 0.030 |
Why?
| | Craniofacial Abnormalities | 1 | 2014 | 76 | 0.030 |
Why?
| | Genes, p53 | 1 | 1994 | 67 | 0.030 |
Why?
| | Vitamin B 12 | 1 | 2014 | 127 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2016 | 436 | 0.030 |
Why?
| | Neural Crest | 1 | 2014 | 126 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 336 | 0.020 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2013 | 32 | 0.020 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 25 | 0.020 |
Why?
| | Atrophy | 1 | 2013 | 201 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2013 | 307 | 0.020 |
Why?
| | Gene Expression | 1 | 2018 | 1490 | 0.020 |
Why?
| | Protein Folding | 1 | 2014 | 279 | 0.020 |
Why?
| | 3T3-L1 Cells | 1 | 2012 | 36 | 0.020 |
Why?
| | Enzyme Activation | 2 | 2006 | 766 | 0.020 |
Why?
| | Middle Aged | 2 | 2007 | 35875 | 0.020 |
Why?
| | Alleles | 1 | 2015 | 879 | 0.020 |
Why?
| | Drinking Behavior | 1 | 2012 | 13 | 0.020 |
Why?
| | Thermogenesis | 1 | 2012 | 45 | 0.020 |
Why?
| | Chondrocytes | 1 | 2014 | 232 | 0.020 |
Why?
| | Dentate Gyrus | 1 | 2012 | 40 | 0.020 |
Why?
| | Maze Learning | 1 | 2012 | 103 | 0.020 |
Why?
| | Cell Size | 1 | 2012 | 92 | 0.020 |
Why?
| | Neuroimmunomodulation | 1 | 2012 | 68 | 0.020 |
Why?
| | Activating Transcription Factor 4 | 1 | 2012 | 22 | 0.020 |
Why?
| | Organ Size | 1 | 2013 | 463 | 0.020 |
Why?
| | Nootropic Agents | 1 | 2011 | 30 | 0.020 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1995 | 419 | 0.020 |
Why?
| | Transfection | 1 | 1994 | 940 | 0.020 |
Why?
| | Cellular Senescence | 1 | 1994 | 226 | 0.020 |
Why?
| | Cell Count | 1 | 2012 | 320 | 0.020 |
Why?
| | Mitochondrial Proteins | 1 | 2013 | 262 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 2011 | 251 | 0.020 |
Why?
| | Insulin | 1 | 2002 | 2507 | 0.020 |
Why?
| | Adiponectin | 1 | 2013 | 244 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2012 | 232 | 0.020 |
Why?
| | Odorants | 1 | 2011 | 116 | 0.020 |
Why?
| | Stem Cells | 1 | 2014 | 626 | 0.020 |
Why?
| | Zebrafish | 1 | 2014 | 528 | 0.020 |
Why?
| | Cell Movement | 1 | 2014 | 965 | 0.020 |
Why?
| | Binding Sites | 2 | 2006 | 1329 | 0.020 |
Why?
| | Computer Simulation | 1 | 2014 | 1025 | 0.020 |
Why?
| | Sinus of Valsalva | 1 | 2009 | 11 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1306 | 0.020 |
Why?
| | Random Allocation | 1 | 2010 | 363 | 0.020 |
Why?
| | Time Factors | 1 | 2000 | 7173 | 0.020 |
Why?
| | Cohort Studies | 1 | 2020 | 5960 | 0.020 |
Why?
| | Apolipoproteins E | 1 | 2009 | 94 | 0.020 |
Why?
| | Models, Molecular | 1 | 2014 | 1618 | 0.020 |
Why?
| | Lactation | 1 | 2010 | 192 | 0.020 |
Why?
| | Immunoblotting | 1 | 2009 | 300 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1098 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2009 | 200 | 0.020 |
Why?
| | Visual Perception | 1 | 2010 | 183 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 2 | 2004 | 2527 | 0.020 |
Why?
| | Protein Binding | 1 | 2014 | 2273 | 0.020 |
Why?
| | Transcription, Genetic | 2 | 2006 | 1496 | 0.020 |
Why?
| | Choline Deficiency | 1 | 2007 | 10 | 0.020 |
Why?
| | Acute-Phase Reaction | 1 | 2007 | 37 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2020 | 3863 | 0.020 |
Why?
| | Cytochrome P-450 CYP2E1 | 1 | 2007 | 30 | 0.020 |
Why?
| | Time | 1 | 2007 | 86 | 0.020 |
Why?
| | eIF-2 Kinase | 1 | 2007 | 29 | 0.020 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2007 | 33 | 0.020 |
Why?
| | Transcription Factor CHOP | 1 | 2007 | 32 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2008 | 427 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2007 | 153 | 0.020 |
Why?
| | Sequence Analysis, Protein | 1 | 2006 | 33 | 0.020 |
Why?
| | Lipase | 1 | 2007 | 75 | 0.020 |
Why?
| | Tyrosine | 1 | 2007 | 222 | 0.020 |
Why?
| | Animals, Genetically Modified | 1 | 2007 | 250 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2009 | 1253 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2012 | 935 | 0.020 |
Why?
| | Solvents | 1 | 2006 | 113 | 0.010 |
Why?
| | Snail Family Transcription Factors | 1 | 2006 | 18 | 0.010 |
Why?
| | Placentation | 1 | 2006 | 53 | 0.010 |
Why?
| | Blotting, Southern | 1 | 2006 | 85 | 0.010 |
Why?
| | Gene Duplication | 1 | 2006 | 67 | 0.010 |
Why?
| | Lipid Metabolism | 1 | 2009 | 527 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 2006 | 187 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2925 | 0.010 |
Why?
| | Executive Function | 1 | 2010 | 461 | 0.010 |
Why?
| | Tetralogy of Fallot | 1 | 2006 | 76 | 0.010 |
Why?
| | Aorta | 1 | 2007 | 429 | 0.010 |
Why?
| | Rats, Wistar | 1 | 2005 | 451 | 0.010 |
Why?
| | Alzheimer Disease | 1 | 2010 | 621 | 0.010 |
Why?
| | Mothers | 1 | 2010 | 775 | 0.010 |
Why?
| | Kidney | 1 | 2012 | 1495 | 0.010 |
Why?
| | NF-kappa B | 1 | 2007 | 661 | 0.010 |
Why?
| | Triamcinolone | 1 | 2002 | 13 | 0.010 |
Why?
| | Body Weight | 1 | 2007 | 976 | 0.010 |
Why?
| | Liver Neoplasms, Experimental | 1 | 2002 | 26 | 0.010 |
Why?
| | Biotinylation | 1 | 2002 | 37 | 0.010 |
Why?
| | Holoenzymes | 1 | 2002 | 25 | 0.010 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 1 | 2002 | 24 | 0.010 |
Why?
| | Dimerization | 1 | 2002 | 194 | 0.010 |
Why?
| | Mutagenesis | 1 | 2002 | 192 | 0.010 |
Why?
| | Phosphorylation | 1 | 2005 | 1732 | 0.010 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2002 | 198 | 0.010 |
Why?
| | Catalytic Domain | 1 | 2001 | 232 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2002 | 675 | 0.010 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2002 | 370 | 0.010 |
Why?
| | Minisatellite Repeats | 1 | 1998 | 36 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1998 | 157 | 0.010 |
Why?
| | Alu Elements | 1 | 1998 | 29 | 0.010 |
Why?
| | Hot Temperature | 1 | 2001 | 407 | 0.010 |
Why?
| | Exons | 1 | 1998 | 358 | 0.010 |
Why?
| | Liver Neoplasms | 1 | 2002 | 780 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 1998 | 612 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1998 | 824 | 0.010 |
Why?
| | Tristetraprolin | 1 | 1995 | 8 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2010 | 11679 | 0.010 |
Why?
| | Hypoglycemic Agents | 1 | 2002 | 1387 | 0.010 |
Why?
| | Blood Glucose | 1 | 2002 | 2327 | 0.010 |
Why?
|
|
MacLean's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|